247 related articles for article (PubMed ID: 18473841)
21. Three-dimensional structures in the design of therapeutics targeting parasitic protozoa: reflections on the past, present and future.
Hol WG
Acta Crystallogr F Struct Biol Commun; 2015 May; 71(Pt 5):485-99. PubMed ID: 25945701
[TBL] [Abstract][Full Text] [Related]
22. [CHARACTERISTICS OF PARASITIC PROTOZOA METABOLISM AND POSSIBILITIES OF ANTIPROTOZOA DRUG DEVELOPMENT (REVIEW)].
Larina S; Sakharova T; Chebyshev N; Berechikidze I; Derkacheva N
Georgian Med News; 2018 Jun; (279):171-175. PubMed ID: 30035741
[TBL] [Abstract][Full Text] [Related]
23. The plastid-like organelle of apicomplexan parasites as drug target.
Wiesner J; Reichenberg A; Heinrich S; Schlitzer M; Jomaa H
Curr Pharm Des; 2008; 14(9):855-71. PubMed ID: 18473835
[TBL] [Abstract][Full Text] [Related]
24. Polyamine transport in parasites: a potential target for new antiparasitic drug development.
Reguera RM; Tekwani BL; Balaña-Fouce R
Comp Biochem Physiol C Toxicol Pharmacol; 2005 Feb; 140(2):151-64. PubMed ID: 15907761
[TBL] [Abstract][Full Text] [Related]
25. Understanding drug resistance in human intestinal protozoa.
El-Taweel HA
Parasitol Res; 2015 May; 114(5):1647-59. PubMed ID: 25782683
[TBL] [Abstract][Full Text] [Related]
26. [Nitric oxide and anti-protozoan chemotherapy].
Gradoni L; Ascenzi P
Parassitologia; 2004 Jun; 46(1-2):101-3. PubMed ID: 15305696
[TBL] [Abstract][Full Text] [Related]
27. Kinetoplast as a potential chemotherapeutic target of trypanosomatids.
Motta MC
Curr Pharm Des; 2008; 14(9):847-54. PubMed ID: 18473834
[TBL] [Abstract][Full Text] [Related]
28. Scientific hypothesis: a new strategy for the design of anti-protozoal drugs--DNA polymerase as a drug target.
Biñas M; Johnson AM
Appl Parasitol; 1994 Sep; 35(3):157-68. PubMed ID: 7951392
[TBL] [Abstract][Full Text] [Related]
29. Protein kinases as targets for anti-parasitic chemotherapy.
Doerig C
Biochim Biophys Acta; 2004 Mar; 1697(1-2):155-68. PubMed ID: 15023358
[TBL] [Abstract][Full Text] [Related]
30. Special organelles of some pathogenic protozoa.
de Souza W
Parasitol Res; 2002 Dec; 88(12):1013-25. PubMed ID: 12444449
[TBL] [Abstract][Full Text] [Related]
31. The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases - part I.
Schmidt TJ; Khalid SA; Romanha AJ; Alves TM; Biavatti MW; Brun R; Da Costa FB; de Castro SL; Ferreira VF; de Lacerda MV; Lago JH; Leon LL; Lopes NP; das Neves Amorim RC; Niehues M; Ogungbe IV; Pohlit AM; Scotti MT; Setzer WN; de N C Soeiro M; Steindel M; Tempone AG
Curr Med Chem; 2012; 19(14):2128-75. PubMed ID: 22414103
[TBL] [Abstract][Full Text] [Related]
32. Polyamine metabolism as chemotherapeutic target in protozoan parasites.
Bacchi CJ; Yarlett N
Mini Rev Med Chem; 2002 Dec; 2(6):553-63. PubMed ID: 12370040
[TBL] [Abstract][Full Text] [Related]
33. The Potential of Secondary Metabolites from Plants as Drugs or Leads against Protozoan Neglected Diseases-Part III: In-Silico Molecular Docking Investigations.
Ogungbe IV; Setzer WN
Molecules; 2016 Oct; 21(10):. PubMed ID: 27775577
[TBL] [Abstract][Full Text] [Related]
34. Genomic databases and the search of protein targets for protozoan parasites.
Timmers LF; Pauli I; Barcellos GB; Rocha KB; Caceres RA; de Azevedo WF; Soares MB
Curr Drug Targets; 2009 Mar; 10(3):240-5. PubMed ID: 19275560
[TBL] [Abstract][Full Text] [Related]
35. The apicoplast as a potential therapeutic target in Toxoplasma and other apicomplexan parasites: some additional thoughts.
Roos DS
Parasitol Today; 1999 Jan; 15(1):41. PubMed ID: 10234180
[No Abstract] [Full Text] [Related]
36. Development of cysteine protease inhibitors as chemotherapy for parasitic diseases: insights on safety, target validation, and mechanism of action.
McKerrow JH
Int J Parasitol; 1999 Jun; 29(6):833-7. PubMed ID: 10480720
[TBL] [Abstract][Full Text] [Related]
37. Old Antiprotozoal Drugs: Are They Still Viable Options for Parasitic Infections or New Options for Other Diseases?
Cortez-Maya S; Moreno-Herrera A; Palos I; Rivera G
Curr Med Chem; 2020; 27(32):5403-5428. PubMed ID: 31264538
[TBL] [Abstract][Full Text] [Related]
38. Editorial: Innovative Therapeutic and Immunomodulatory Strategies for Protozoan Infections.
Gómez Marín JE; El Bissati K
Front Cell Infect Microbiol; 2019; 9():293. PubMed ID: 31448246
[No Abstract] [Full Text] [Related]
39. The apicoplast as a potential therapeutic target in and other apicomplexan parasites.
Soldati D
Parasitol Today; 1999 Jan; 15(1):5-7. PubMed ID: 10234168
[No Abstract] [Full Text] [Related]
40. Amphibian antimicrobial peptides and Protozoa: lessons from parasites.
Rivas L; Luque-Ortega JR; Andreu D
Biochim Biophys Acta; 2009 Aug; 1788(8):1570-81. PubMed ID: 19046939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
